Skip to content

Clinical trials

Cholangiocarcinoma trials in Thailand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Thailand Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20141
20161
20173
20181
20192
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Unknown status2
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company2
AstraZeneca1
Halozyme Therapeutics1
Incyte Corporation1
Khon Kaen University1
MacroGenics1
Mahidol University1
McMaster University1
Merck Sharp & Dohme LLC1
National Science and Technology Development Agency, Thailand1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma12
Bile Duct Neoplasms3
Gallbladder Neoplasms2
Acrocephalosyndactylia1
Biliary Tract Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Hematologic Neoplasms1
Klatskin Tumor1
Neuroblastoma1
Opisthorchiasis1

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.